SCOLR Pharma, Inc. Reports Second Quarter 2009 Financial Results
... period in 2008. This decrease is primarily due to lower
royalty income from our relationship with ... period in 2008. This decrease is primarily due to lower
royalty income from our relationship with ... expenses due to reduction in personnel and lower
advertising and tradeshow expenses. In addition, ...
GenVec Reports Second Quarter 2009 Financial Results
... compared to the comparable prior year periods. lower
revenues under both the FMD and malaria programs ... to the prior year. Also contributing to the lower
revenue under the malaria program for the ... The decrease in both periods is primarily due to lower
personnel costs, reduced patient, site, lab, data ...
InterMune Reports Second Quarter 2009 Financial Results and Business Highlights
... a decrease of approximately 2 percent, reflecting lower
off-label physician prescriptions of Actimmune ... decrease of approximately 17 percent, reflecting lower
off-label sales of Actimmune for the treatment of ... strategy are less frequent administration and a lower
dose or pill burden for ITMN-191, which may ...
Telik Announces Second Quarter 2009 Financial Results
... Operating expenses were approximately 43% lower
in the second quarter of 2009 compared with the same period in 2008, primarily due to lower
headcount as a result of our restructuring in ... research, clinical trial and related expenses and lower
stock compensation expense.
For the six ...
Angiotech Pharmaceuticals, Inc. announces financial results for the second quarter ended June 30, 2009
... to the second quarter of 2008 is due primarily to lower
sales of medical device components to other third ... The decrease in royalty revenues was a result of lower
sales of TAXUS stents by BSC, driven primarily by ... thinner stent struts, increased flexibility and a lower
stent profile while improving radial strength, ...
PDI Reports 2009 Second Quarter Financial Results
... ago period. These declines are primarily due to lower
revenue. The overall increase in second quarter ... 2009 operating expenses were $1.0 million, or 9%, lower
than 2008. This decline is primarily attributable ... in 2009 compared to 2008 due to a combination of lower
available cash and cash equivalents and the ...
Shire plc: Core Portfolio of Products Delivers 20% Sales Growth
... 53%, or $131 million to $116
million as the lower
ADDERALL XR revenues in Q2 2009 were partially
... offset by higher revenues on other products and lower
expenses on a Non GAAP basis. On ... 53% to $115.5 million (2008: $246.5 million). The lower
product sales of
ADDERALL XR in Q2 2009 were ...
SENOMYX ANNOUNCES CORPORATE UPDATE AND SECOND QUARTER 2009 FINANCIAL RESULTS
... enhancer could potentially allow the usage of lower
quantities of Reb-A, maintaining the desired ... Also contributing to these decreases were lower
patent and trademark expenses primarily ... Company's intellectual property portfolio, and lower
non-cash stock-based compensation expenses. ...
Techne Corporation Releases Unaudited Fourth Quarter Results for Fiscal Year 2009
... of fiscal 2009. The Company attributes the lower
fourth quarter sales growth rate to continued ... year ended June 30, 2009 were primarily caused by lower
gross margins in Europe resulting from ... higher margin Biotechnology Division sales to lower
margin Hematology Division and R&D Europe ...
Mylan Reports Adjusted Diluted EPS of $0.32 for the Quarter Ended June 30, 2009
... largest market, and the U.K. served to offset lower
revenue in Germany. In France, revenues ... to increased sales and gross profit, as well as lower
R&D expense, partially offset by higher ... made in December 2008 and March 2009, as well as lower
overall interest rates. Other income, net, for ...
Sigma-Aldrich (Nasdaq:SIAL) Reports Q2 2009 Diluted EPS of $0.68; YTD Diluted EPS up 1.5% to $1.36. Full Year 2009 Guidance Reaffirmed, With 2009 Diluted EPS Expected to Exceed 2008's $2.65.
... benefits from global supply chain activities, lower
S,G&A costs and strategic pricing actions to ... continuation of the cost improvement efforts, lower
interest rates, and exchange rates remaining at ... to the timing of international tax payments, a lower
level of net income and a small increase in ...
New Report Just Published: World Prostate Cancer Therapeutics Market Report
... Cancer, Cerebrovascular Diseases,
Respiratory Diseases, and Accidents
... Cancer, Cerebrovascular diseases, Chronic lower
diseases, Accidents ... Cancer, Cerebrovascular Diseases,
Respiratory Diseases, and Accidents
Helix BioPharma Announces Q3 2009 Financial Results and Provides Product Development Update
... in part, higher purchase costs resulting from a lower
Canadian dollar versus the U.S. dollar and ... the aforementioned increases in expenditures are lower
wages and benefits from the foregoing of accrued ... by management during the current fiscal year and lower
wages and benefits due to a one-time charge ...
Lumbar Matrix(TM) Scan From SpineMatrix(R) Revolutionizes the Diagnosis of Low Back Pain
... diagnostic methods used most frequently to detect lower
back pain - such as X-rays, magnetic resonance ... including surgery, may follow misdiagnosed lower
back pain, further elevating healthcare spending. ... which helps physicians to differentially diagnose lower
back pain by identifying disc, facet and muscle ...
OncoGenex Pharmaceuticals Announces OGX-011 Treatment Provides Survival Benefit in Randomized Phase 2 Trial in Advanced Metastatic Prostate Cancer
... with OGX-011 had a rate of death 51%
than patients treated with docetaxel alone ... exploratory analyses found that the
rate of death was associated with the effect of ... (i.e. OGX-011 treatment resulted in a lower
rate of death when
compared to the ...
Centocor Ortho Biotech Data to be Presented at American Society of Clinical Oncology (ASCO) Annual Meeting
Cardiac toxicity may also occur at lower
cumulative doses (400 mg/m2) in patients with ... than or equal to 5% decrease below institutional lower
limit of normal)
... agents (ESAs) to target higher versus lower
hemoglobin levels (13.5 vs. 11.3 g/dL; 14 vs. 10 ...
Insmed Announces First Quarter 2009 Financial Results
... most recent first quarter of $23,000 was $256,000 lower
than the corresponding quarter of 2008 due to a combination of the lower
interest rate environment and a lower
average cash balance. Interest expense of ...
SENOMYX ANNOUNCES FIRST QUARTER 2009 FINANCIAL RESULTS
... in 2008. The decrease was primarily due to lower
costs related to scientific supplies and lower
General and ... the research funding period by one year and lower
the funding that Senomyx will receive to reflect ...
Savient Pharmaceuticals Reports First Quarter 2009 Financial Results
... ended March 31, 2008. The decrease was due to lower
gross product sales of Oxandrin(R), our product ... impact of generic competition partially offset by lower
provisions for product returns year over year. ... Partially offsetting these higher expenses were lower
validation and technology transfer costs relating ...
Solutia Reports First Quarter 2009 Results
... in all world markets, partially offset by lower
raw material and SG&A costs, and higher ... in the same period in 2008, primarily due to lower
window films revenue, partially offset by reduced ... in the prior year period, primarily due to lower
volumes partially offset by improved selling ...
Cambrex Reports First Quarter 2009 Results
... quarter 2009 sales of $60.0 million were 2.8% lower
than the first quarter 2008. Sales were ... custom development revenues, partially offset by lower
sales of generic APIs.
First quarter 2009 ... favorably impacting gross margin by 6.0%. lower
production levels and the ...
Shire begins the year with a strong performance
... basis) with higher revenues
supported by lower
costs driving improved margins. The lower
a result of our increased focus ... income for the three
months to March 31, 2009 is lower
than the same period in 2008 due to lower
Covance Reports First Quarter Revenue of $441M and EPS of $0.63; Updates Full Year Financial Targets
... and slower than originally projected and from a lower
base of revenue. As a result, we are now ... $214.2 million in the fourth quarter of 2008. lower
demand across most of the segment's service ... quarter operating margins were impacted by a lower
level of study activity, costs related to the ...
ViroPharma Incorporated Reports First Quarter 2009 Financial Results
... write off arising from our book value being lower
than our market capitalization at March 31, 2009, ... to the price increase in January 2009, offset by lower
Cost of sales increased over ... write off arising from our book value being lower
than our market capitalization at March 31, 2009, ...
Under the Microscope: 'Micro IVF'
... syndrome or producing financial hardship. Its lower
cost and risk should outweigh diminished ... IVF, but because of the economy they opt for the lower
price and subsequently, the lower
chance of success. It worries me that in order to ...
Techne Corporation Releases Unaudited Third Quarter Results for Fiscal Year 2009
... the same period. The Company attributes the lower
third quarter sales growth rate to customer ... in the third quarter was primarily caused by lower
gross margins in Europe resulting from ... prior-year periods, primarily as a result of lower
rates of return on cash and available-for-sale ...
Flu vaccine given in microneedle skin patches proves effective in mice
... because of decreased pain, increased convenience, lower
cost and simpler logistics over conventional ... convenient storage, easier transportation and lower
dosage requirements. lower
doses could be particularly important because flu ...
First Application to Fight High Cholesterol Launches on the iPhone and iPod Touch
... to track their cholesterol and, more importantly, lower
their cholesterol by putting together an action ... to track their cholesterol and, more importantly, lower
their cholesterol by putting together an action ... of the application is to motivate people to lower
their cholesterol and keep it low. If the user ...
New Generation Biofuels Signs Sales Contract with Catoctin Mountain Growers to Supply up to 370,000 gallons of Renewable Biofuel
... Growers with our biofuel, which provides a lower
carbon footprint and is 100 percent renewable," ... when replicated across the country, will help lower
the net emission of greenhouse gases in the ... that its proprietary biofuel can provide a lower
cost, renewable alternative energy source with ...
WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2008 Results
... of acquired intangible assets in 2008; and lower
margins in our China-based ... 2008 and 44% in full-year 2008 were lower
than 44% and 48%,
respectively, for the ... financial results for AppTec, which had lower
gross margins than our
Publication of Shire plc's Annual Report 2008
... the following, which could result in lower
prices for the Group's products
and/or a reduced ... world market and imports that product
from the lower
price jurisdiction to the higher price jurisdiction. If the
parallel importation of lower
priced drugs is permitted in the US, it ...
ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2008 Financial Results
... in interest income was primarily attributable to lower
invested balances and interest rates.
... and other income was primarily attributable to lower
interest income based on lower
invested balances, offset by $0.1 million ...
Helix BioPharma Announces Q2 2009 Financial Results
... reflects higher purchase costs resulting from a lower
Canadian dollar versus the U.S. dollar.
... the aforementioned increases in expenditures are lower
wages and benefits due to a one-time charge ... ended January 31, 2008. Also contributing to the lower
wages and benefits in the current quarter was the ...
AEterna Zentaris Reports Fourth Quarter and Full-Year 2008 Financial and Operating Results
... The decrease in revenues is primarily due to lower
quarter-over-quarter royalties related to our ... still recognized as royalty revenues, has been lower
than the royalty revenues recognized in the past, ... loss is largely attributable to a combination of lower
sales and ...
Insmed Announces Fourth Quarter and Full-Year 2008 Financial Results
... of 2007. This was due to the combination of a lower
average cash balance on hand and lower
interest rates during the most recent quarter. ... full-year 2007. This decrease was mainly due to lower
interest rates and ...
Angiotech Pharmaceuticals, Inc. announces financial results for the fourth quarter ended December 31, 2008
... to achieve
higher sales during 2008 on lower
absolute levels of selling, general
and ... has declined significantly, primarily due to lower
than expected royalties derived from sales by our ... our business and cash position (including lower
expected revenues derived from BSC), we did not ...
Vasogen Announces 2008 Year-End Results
... period in 2007. A key driver of this decrease was lower
compensation costs, reduced stock compensation expense, lower
infrastructure and other support costs driven by lower
employee numbers in 2008, and a decrease in the ...
NOVAVAX Announces Preclinical Study Results for a Respiratory Syncytial Virus ('RSV') Vaccine Candidate Directed Against the Fusion (F) Protein
... which are important for preventing infection and lower
respiratory illness, were highest in the "VLP ...
RSV is the most commonly identified cause of lower
respiratory tract infection in infants and young ... less than four years of age) may also develop lower
respiratory tract infections leading to ...
INVO Bioscience Completes Reverse Merger
... "the company"), focused on creating simplified, lower
cost treatment option for patients diagnosed with ... stimulation infertility treatment cycle, using lower
amounts of injectable fertility hormones than ... Massachusetts, focused on creating simplified, lower
cost treatment options for patients diagnosed ...
Mylan Reports Adjusted Diluted EPS of $0.26 for the Quarter Ended Dec. 31, 2008, and Adjusted Diluted EPS of $0.80 for the Year Ended Dec. 31, 2008
... markets, France and Germany, partially offset by lower
sales in the United Kingdom.
Asia Pacific ... to a new distribution partner, resulted in lower
year-over-year sales in that country. These ... sales and gross profit, as well as slightly lower
R&D and SG&A expense, both of which ...